chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dysstasia, Fatigue, Feeling abnormal, Malaise
Clinical narrative: sleepiness; weakness; malaise; brain fog; inability to rise from her bed the morning; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog) and DYSSTASIA (inability to rise from her bed the morning) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve replacement (significant for valve replacement) in May 2020 and Pacemaker insertion (cardiac) in May 2020.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue). On 24-Feb-2021, SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Both medical history were added.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: sleepiness; weakness; malaise; brain fog; inability to rise from her bed the morning; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog) and DYSSTASIA (inability to rise from her bed the morning) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve replacement (significant for valve replacement) in May 2020 and Pacemaker insertion (cardiac) in May 2020.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue). On 24-Feb-2021, SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Both medical history were added.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dry mouth, Irritable bowel syndrome, Nausea, Vaccination site pain
Clinical narrative: Dry mouth at night; cramping in her stomach; IBS maybe actin up; pain at the injection site; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 02-Feb-2021, the patient experienced DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea).   At the time of the report, DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Injection site pain, Rhinorrhoea
Clinical narrative: sore arm; Runny Nose; not sure if 0.5mL. Had both injections; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (sore arm), RHINORRHOEA (Runny Nose) and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced INJECTION SITE PAIN (sore arm), RHINORRHOEA (Runny Nose) and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections).   At the time of the report, INJECTION SITE PAIN (sore arm) and RHINORRHOEA (Runny Nose) outcome was unknown and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections) had resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Instillation site induration
Clinical narrative: Bellafill facial filler was "hard as a rock"; This spontaneous case was reported by a consumer and describes the occurrence of INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock") in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Dermal filler injection (Patient states the filler was put in 5 years ago) since April 2016. Concurrent medical conditions included Food allergy (Patient is allergic to wheat and oats) and Shellfish allergy (Patient is allergic to Shellfish allergy).  On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 26-Feb-2021, the patient experienced INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock"). At the time of the report, INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock") outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Rash, Urticaria, Vaccination complication
Clinical narrative: Describes the rash as hives; Woke up with rash on the lower half of her face and neck; Fever of 102F after 2nd dose; Severe reaction after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION COMPLICATION (Severe reaction after 2nd dose). On 23-Feb-2021, the patient experienced PYREXIA (Fever of 102F after 2nd dose). On 25-Feb-2021, the patient experienced URTICARIA (Describes the rash as hives) and RASH (Woke up with rash on the lower half of her face and neck). At the time of the report, URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 102 (Inconclusive) 102 F.         No concomitant and treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-026651 (Patient Link).
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: urinary track infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary track infection) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced URINARY TRACT INFECTION (urinary track infection). The patient was treated with CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) ongoing from 24-Feb-2021 for UTI, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (urinary track infection) outcome was unknown.            Concomitant product use was not reported.  Treatment product use was not reported.  Follow up email received on 01Jul2021 from the reporter states that there was no remarkable connection of urinary tract infection to Moderna vaccine   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Correspondence follow up email attached: casuality updated
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Movement disorder, Myalgia
Clinical narrative: Upper arm soreness; Muscle soreness; Pain when lifting arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL, LOSARTAN, ATORVASTATIN, VITAMIN supplements, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), HCTZ, RALOXIFENE and IBANDRONATE SODIUM (IBANDRONATE) for an unknown indication.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Feb-2021, the patient experienced AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm).   At the time of the report, AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Electric shock
Clinical narrative: "electrical shot" all over body; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.            24Feb2021 Within 30 minutes after vaccination, Patient felt like an "electric shot" all over body.  Action taken with mRNA-1273 in response to the events was not Applicable.   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: One leg has little red spots on it, like a rash; Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together). At the time of the report, RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.  Patient gave consent to safety for Follow-up.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: sick to the stomach; Diarrhea; didn't feel like eating anything; Sore Throat; Swollen; Runny nose; hot and cold; Sore; tired; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat) and SWELLING (Swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020 and Pneumonia in April 2021. Concurrent medical conditions included Gout, Urine abnormality, Hypertension, Neuralgia, Kidney disorder, Allergy and Hypercholesteraemia. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, ALLOPURINOL for Gout, FISH OIL for Hypercholesterolaemia, ATENOLOL for Hypertension, CALCITRIOL for Kidney disorder, SERTRALINE for Neuralgia, BUMETANIDE for Urine abnormality, SALBUTAMOL (ALBUTEROL HFA) and VITAMIN D NOS for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency.   At the time of the report, ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 antibody test: positive (Positive) Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to MOD-2021-106316 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details updated, concomitant and medical history added, new event diarrhea added AND second dose events new case created and linked
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea
Clinical narrative: sick to the stomach; Diarrhea; didn't feel like eating anything; Sore Throat; Swollen; Runny nose; hot and cold; Sore; tired; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat) and SWELLING (Swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020 and Pneumonia in April 2021. Concurrent medical conditions included Gout, Urine abnormality, Hypertension, Neuralgia, Kidney disorder, Allergy and Hypercholesteraemia. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, ALLOPURINOL for Gout, FISH OIL for Hypercholesterolaemia, ATENOLOL for Hypertension, CALCITRIOL for Kidney disorder, SERTRALINE for Neuralgia, BUMETANIDE for Urine abnormality, SALBUTAMOL (ALBUTEROL HFA) and VITAMIN D NOS for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency.   At the time of the report, ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 antibody test: positive (Positive) Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to MOD-2021-106316 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details updated, concomitant and medical history added, new event diarrhea added AND second dose events new case created and linked
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Swelling
Clinical narrative: sick to the stomach; Diarrhea; didn't feel like eating anything; Sore Throat; Swollen; Runny nose; hot and cold; Sore; tired; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat) and SWELLING (Swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020 and Pneumonia in April 2021. Concurrent medical conditions included Gout, Urine abnormality, Hypertension, Neuralgia, Kidney disorder, Allergy and Hypercholesteraemia. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, ALLOPURINOL for Gout, FISH OIL for Hypercholesterolaemia, ATENOLOL for Hypertension, CALCITRIOL for Kidney disorder, SERTRALINE for Neuralgia, BUMETANIDE for Urine abnormality, SALBUTAMOL (ALBUTEROL HFA) and VITAMIN D NOS for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency.   At the time of the report, ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 antibody test: positive (Positive) Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   This case was linked to MOD-2021-106316 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details updated, concomitant and medical history added, new event diarrhea added AND second dose events new case created and linked
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chattering teeth/Chills; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (chattering teeth/Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced CHILLS (chattering teeth/Chills). At the time of the report, CHILLS (chattering teeth/Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Body temperature, Chills, Dyskinesia, Headache
Clinical narrative: Mouth turned to the left side; Body aches; Abdominal pain; Trembling really strong; Extreme sweat; Pain in the left leg; Headache; Fever of 101°F; Chills; This spontaneous case was reported by a nurse and describes the occurrence of DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong) and HYPERHIDROSIS (Extreme sweat) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma and Hypertension. Concurrent medical conditions included Anxiety, Blood pressure high, Allergic reaction to food, Allergic reaction to drug and Penicillin allergy.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 20-Feb-2021, the patient experienced DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PAIN IN EXTREMITY (Pain in the left leg), HEADACHE (Headache), PYREXIA (Fever of 101°F) and CHILLS (Chills).   On 25-Feb-2021, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PYREXIA (Fever of 101°F) and CHILLS (Chills) had resolved. At the time of the report, DYSKINESIA (Mouth turned to the left side), PAIN IN EXTREMITY (Pain in the left leg) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 101 (High) High.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that patient is currently consuming High blood pressure and Anxiety medication.   This case was linked to MOD-2021-026852 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain, Pain in extremity, Pyrexia, Tremor
Clinical narrative: Mouth turned to the left side; Body aches; Abdominal pain; Trembling really strong; Extreme sweat; Pain in the left leg; Headache; Fever of 101°F; Chills; This spontaneous case was reported by a nurse and describes the occurrence of DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong) and HYPERHIDROSIS (Extreme sweat) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma and Hypertension. Concurrent medical conditions included Anxiety, Blood pressure high, Allergic reaction to food, Allergic reaction to drug and Penicillin allergy.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 20-Feb-2021, the patient experienced DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PAIN IN EXTREMITY (Pain in the left leg), HEADACHE (Headache), PYREXIA (Fever of 101°F) and CHILLS (Chills).   On 25-Feb-2021, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PYREXIA (Fever of 101°F) and CHILLS (Chills) had resolved. At the time of the report, DYSKINESIA (Mouth turned to the left side), PAIN IN EXTREMITY (Pain in the left leg) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 101 (High) High.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It is reported that patient is currently consuming High blood pressure and Anxiety medication.   This case was linked to MOD-2021-026852 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue
Clinical narrative: dizziness; weakness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 06-Feb-2021, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue).   At the time of the report, DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discharge
Clinical narrative: Leaked from patient's arm; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE DISCHARGE (Leaked from patient's arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Leaked from patient's arm). At the time of the report, VACCINATION SITE DISCHARGE (Leaked from patient's arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported  No treatment was specified
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 08-Feb-2021, the patient experienced ADVERSE REACTION (Adverse reaction). At the time of the report, ADVERSE REACTION (Adverse reaction) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Swelling
Clinical narrative: Hurt quite a bit; Upper arm was swollen and red; Upper arm was swollen and red; Got kind of lumpy and hurt quite a bit for about 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included BISOPROLOL, VERAPAMIL, CANDESARTAN, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and TIOTROPIUM BROMIDE (SPIRIVA) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient took second dose on 24-FEB-2021.   This case was linked to MOD-2021-040508 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus
Clinical narrative: Itchiness; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M2014) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Breast pain
Clinical narrative: Pain in the collar bone and near the breast; soreness; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX), SERTRALINE, ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO), CETIRIZINE, SIMVASTATIN and PANTOPRAZOLE for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Second dosing regimen added. Action taken updated from unknown to not applicable. Preferred term updated for pain. Outcome updated.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Rash erythematous, Rash pruritic
Clinical narrative: also left chest pain; red rush on the left side of her chest in the back and front; itchy rush on the left side of her chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included INSULIN and METFORMIN for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Jan-2021, the patient experienced CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest).   On 31-Jan-2021, CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: Swelling of the throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: chills; fever of 99.6F; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Hypertension, MAGNESIUM, VITAMIN C [ASCORBIC ACID], ZINC and AMYLASE, ASCORBIC ACID, CELLULASE, FOLIC ACID, LIPASE, PROTEASE NOS (JUICE PLUS) for an unknown indication.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Pyrexia: 99.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-029583 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Hypertension, MAGNESIUM, VITAMIN C [ASCORBIC ACID], ZINC and AMYLASE, ASCORBIC ACID, CELLULASE, FOLIC ACID, LIPASE, PROTEASE NOS (JUICE PLUS) for an unknown indication.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Pyrexia: 99.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-029583 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Injection site pain, Myalgia
Clinical narrative: pain at the injection site; fever; chills; muscle aches; joint paint; Changes in the way some things smell; Loss of appetite; A spontaneous report was received from a consumer a 43-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever/Pyrexia, pain at the injection site/Injection site pain, chills, muscle aches/Myalgia, joint paint/Arthralgia, Changes in the way some things smell/Parosmia, Loss of appetite/Decreased appetite. The patient's medical history was not provided by the reporter. Concomitant medications was not provided by the reporter.   On 1st Feb 2021 the patient received their first of two planned doses of mRNA-1273 intramuscularly in unknown location for prophylaxis of COVID-19 infection.  on 1st Feb prior to receiving mRNA-1273, patient experienced pain at the injection site, fever, chills, muscle aches, joint pains, loss of appetite and changes in the way some things smell. Treatment information is not provided. Action taken with mRNA-1273 in response to the events is not applicable.  The outcome of the event fever, pain at the injection site, chills, muscle aches, joint paint, Changes in the way some things smell, Loss of appetite was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Pyrexia
Clinical narrative: pain at the injection site; fever; chills; muscle aches; joint paint; Changes in the way some things smell; Loss of appetite; A spontaneous report was received from a consumer a 43-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever/Pyrexia, pain at the injection site/Injection site pain, chills, muscle aches/Myalgia, joint paint/Arthralgia, Changes in the way some things smell/Parosmia, Loss of appetite/Decreased appetite. The patient's medical history was not provided by the reporter. Concomitant medications was not provided by the reporter.   On 1st Feb 2021 the patient received their first of two planned doses of mRNA-1273 intramuscularly in unknown location for prophylaxis of COVID-19 infection.  on 1st Feb prior to receiving mRNA-1273, patient experienced pain at the injection site, fever, chills, muscle aches, joint pains, loss of appetite and changes in the way some things smell. Treatment information is not provided. Action taken with mRNA-1273 in response to the events is not applicable.  The outcome of the event fever, pain at the injection site, chills, muscle aches, joint paint, Changes in the way some things smell, Loss of appetite was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Hyperhidrosis, Muscular weakness, Pain in extremity
Clinical narrative: sore arm; SWEATY; weak; Fatigue; thirsty; Left shoulder is weak; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue) and THIRST (thirsty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak) outcome was unknown. Not Provided          No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD-2021-026636 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 25-Feb-2021.    This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue) and THIRST (thirsty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak) outcome was unknown. Not Provided          No relevant Concomitant medications were reported.   No Treatment information for the event was provided.